Sartorius Stedim Biotech Aktie
167,15
EUR
-1,10
EUR
-0,65
%
166,80
EUR
-2,30
EUR
-1,36
%
Werbung
Sartorius Stedim Biotech Aktie Analyse
| 23.04.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
| 12.03.24 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
| 29.09.23 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
| 06.09.23 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
| 11.08.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
| 20.06.23 | Sartorius Stedim Biotech Buy | UBS AG | |
| 19.06.23 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
|
Werbung
|
|||
| 07.03.23 | Sartorius Stedim Biotech Buy | HSBC | |
| 22.07.22 | Sartorius Stedim Biotech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 04.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 22.04.22 | Sartorius Stedim Biotech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.21 | Sartorius Stedim Biotech overweight | JP Morgan Chase & Co. | |
Werbung
Werbung